nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—ALB—Captopril—systemic scleroderma	0.13	0.168	CbGbCtD
Alfentanil—ALB—Mycophenolate mofetil—systemic scleroderma	0.103	0.133	CbGbCtD
Alfentanil—ABCB1—Lisinopril—systemic scleroderma	0.0911	0.118	CbGbCtD
Alfentanil—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0825	0.107	CbGbCtD
Alfentanil—ALB—Prednisone—systemic scleroderma	0.0821	0.106	CbGbCtD
Alfentanil—ABCB1—Captopril—systemic scleroderma	0.0682	0.0881	CbGbCtD
Alfentanil—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0537	0.0694	CbGbCtD
Alfentanil—ABCB1—Prednisone—systemic scleroderma	0.0429	0.0555	CbGbCtD
Alfentanil—ALB—Methotrexate—systemic scleroderma	0.0412	0.0532	CbGbCtD
Alfentanil—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0322	0.0416	CbGbCtD
Alfentanil—CYP3A4—Prednisone—systemic scleroderma	0.0257	0.0332	CbGbCtD
Alfentanil—ABCB1—Methotrexate—systemic scleroderma	0.0215	0.0278	CbGbCtD
Alfentanil—Bradycardia—Lisinopril—systemic scleroderma	0.000849	0.00376	CcSEcCtD
Alfentanil—Euphoric mood—Prednisone—systemic scleroderma	0.000847	0.00375	CcSEcCtD
Alfentanil—Confusional state—Captopril—systemic scleroderma	0.000843	0.00373	CcSEcCtD
Alfentanil—Angiopathy—Mycophenolic acid—systemic scleroderma	0.00084	0.00372	CcSEcCtD
Alfentanil—Anaphylactic shock—Captopril—systemic scleroderma	0.000837	0.0037	CcSEcCtD
Alfentanil—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.000834	0.00369	CcSEcCtD
Alfentanil—Chills—Mycophenolic acid—systemic scleroderma	0.000831	0.00368	CcSEcCtD
Alfentanil—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.000827	0.00366	CcSEcCtD
Alfentanil—Fatigue—Mometasone—systemic scleroderma	0.000821	0.00364	CcSEcCtD
Alfentanil—Tachycardia—Captopril—systemic scleroderma	0.000816	0.00361	CcSEcCtD
Alfentanil—Pain—Mometasone—systemic scleroderma	0.000814	0.00361	CcSEcCtD
Alfentanil—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000813	0.0036	CcSEcCtD
Alfentanil—Mental disorder—Mycophenolic acid—systemic scleroderma	0.000811	0.00359	CcSEcCtD
Alfentanil—Vision blurred—Leflunomide—systemic scleroderma	0.000796	0.00352	CcSEcCtD
Alfentanil—Asthenia—Pentoxifylline—systemic scleroderma	0.000792	0.00351	CcSEcCtD
Alfentanil—Hypotension—Captopril—systemic scleroderma	0.000782	0.00346	CcSEcCtD
Alfentanil—Pruritus—Pentoxifylline—systemic scleroderma	0.000781	0.00346	CcSEcCtD
Alfentanil—Epistaxis—Mycophenolate mofetil—systemic scleroderma	0.000768	0.0034	CcSEcCtD
Alfentanil—Vision blurred—Mycophenolic acid—systemic scleroderma	0.000759	0.00336	CcSEcCtD
Alfentanil—Angiopathy—Lisinopril—systemic scleroderma	0.000757	0.00335	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.000756	0.00335	CcSEcCtD
Alfentanil—Body temperature increased—Mometasone—systemic scleroderma	0.000753	0.00333	CcSEcCtD
Alfentanil—Mediastinal disorder—Lisinopril—systemic scleroderma	0.000751	0.00333	CcSEcCtD
Alfentanil—Chills—Lisinopril—systemic scleroderma	0.000748	0.00331	CcSEcCtD
Alfentanil—Arrhythmia—Lisinopril—systemic scleroderma	0.000745	0.0033	CcSEcCtD
Alfentanil—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.000744	0.00329	CcSEcCtD
Alfentanil—Somnolence—Captopril—systemic scleroderma	0.000744	0.00329	CcSEcCtD
Alfentanil—Agitation—Mycophenolic acid—systemic scleroderma	0.000741	0.00328	CcSEcCtD
Alfentanil—Cough—Leflunomide—systemic scleroderma	0.000737	0.00326	CcSEcCtD
Alfentanil—Mental disorder—Lisinopril—systemic scleroderma	0.000731	0.00323	CcSEcCtD
Alfentanil—Dizziness—Pentoxifylline—systemic scleroderma	0.00073	0.00323	CcSEcCtD
Alfentanil—Hypertension—Leflunomide—systemic scleroderma	0.000729	0.00323	CcSEcCtD
Alfentanil—Erythema—Lisinopril—systemic scleroderma	0.000726	0.00321	CcSEcCtD
Alfentanil—Fatigue—Captopril—systemic scleroderma	0.000721	0.00319	CcSEcCtD
Alfentanil—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.000718	0.00318	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000714	0.00316	CcSEcCtD
Alfentanil—Skin disorder—Azathioprine—systemic scleroderma	0.000709	0.00314	CcSEcCtD
Alfentanil—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000708	0.00314	CcSEcCtD
Alfentanil—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.000704	0.00312	CcSEcCtD
Alfentanil—Cough—Mycophenolic acid—systemic scleroderma	0.000703	0.00311	CcSEcCtD
Alfentanil—Vomiting—Pentoxifylline—systemic scleroderma	0.000702	0.00311	CcSEcCtD
Alfentanil—Convulsion—Mycophenolic acid—systemic scleroderma	0.000698	0.00309	CcSEcCtD
Alfentanil—Rash—Pentoxifylline—systemic scleroderma	0.000696	0.00308	CcSEcCtD
Alfentanil—Hypertension—Mycophenolic acid—systemic scleroderma	0.000696	0.00308	CcSEcCtD
Alfentanil—Dermatitis—Pentoxifylline—systemic scleroderma	0.000695	0.00308	CcSEcCtD
Alfentanil—Headache—Pentoxifylline—systemic scleroderma	0.000691	0.00306	CcSEcCtD
Alfentanil—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000689	0.00305	CcSEcCtD
Alfentanil—Feeling abnormal—Captopril—systemic scleroderma	0.000689	0.00305	CcSEcCtD
Alfentanil—Vision blurred—Lisinopril—systemic scleroderma	0.000684	0.00303	CcSEcCtD
Alfentanil—Asthenia—Mometasone—systemic scleroderma	0.000683	0.00303	CcSEcCtD
Alfentanil—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.000683	0.00302	CcSEcCtD
Alfentanil—Hypotension—Azathioprine—systemic scleroderma	0.000682	0.00302	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000681	0.00302	CcSEcCtD
Alfentanil—Cardiac arrest—Prednisone—systemic scleroderma	0.000681	0.00301	CcSEcCtD
Alfentanil—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000678	0.003	CcSEcCtD
Alfentanil—Nervous system disorder—Leflunomide—systemic scleroderma	0.000676	0.00299	CcSEcCtD
Alfentanil—Pruritus—Mometasone—systemic scleroderma	0.000674	0.00298	CcSEcCtD
Alfentanil—Tachycardia—Leflunomide—systemic scleroderma	0.000673	0.00298	CcSEcCtD
Alfentanil—Skin disorder—Leflunomide—systemic scleroderma	0.00067	0.00296	CcSEcCtD
Alfentanil—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000666	0.00295	CcSEcCtD
Alfentanil—Confusional state—Mycophenolic acid—systemic scleroderma	0.000663	0.00294	CcSEcCtD
Alfentanil—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000663	0.00293	CcSEcCtD
Alfentanil—Body temperature increased—Captopril—systemic scleroderma	0.000661	0.00293	CcSEcCtD
Alfentanil—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000658	0.00292	CcSEcCtD
Alfentanil—Nausea—Pentoxifylline—systemic scleroderma	0.000656	0.0029	CcSEcCtD
Alfentanil—Chills—Mycophenolate mofetil—systemic scleroderma	0.000656	0.0029	CcSEcCtD
Alfentanil—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000653	0.00289	CcSEcCtD
Alfentanil—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000645	0.00286	CcSEcCtD
Alfentanil—Hypotension—Leflunomide—systemic scleroderma	0.000644	0.00285	CcSEcCtD
Alfentanil—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000642	0.00284	CcSEcCtD
Alfentanil—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00064	0.00283	CcSEcCtD
Alfentanil—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000639	0.00283	CcSEcCtD
Alfentanil—Loss of consciousness—Lisinopril—systemic scleroderma	0.000638	0.00282	CcSEcCtD
Alfentanil—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000636	0.00281	CcSEcCtD
Alfentanil—Cough—Lisinopril—systemic scleroderma	0.000633	0.0028	CcSEcCtD
Alfentanil—Visual disturbance—Methotrexate—systemic scleroderma	0.000631	0.00279	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00063	0.00279	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000618	0.00274	CcSEcCtD
Alfentanil—Hypotension—Mycophenolic acid—systemic scleroderma	0.000615	0.00272	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000614	0.00272	CcSEcCtD
Alfentanil—Vomiting—Mometasone—systemic scleroderma	0.000606	0.00268	CcSEcCtD
Alfentanil—Feeling abnormal—Azathioprine—systemic scleroderma	0.000602	0.00266	CcSEcCtD
Alfentanil—Rash—Mometasone—systemic scleroderma	0.000601	0.00266	CcSEcCtD
Alfentanil—Asthenia—Captopril—systemic scleroderma	0.0006	0.00266	CcSEcCtD
Alfentanil—Dermatitis—Mometasone—systemic scleroderma	0.0006	0.00266	CcSEcCtD
Alfentanil—Confusional state—Lisinopril—systemic scleroderma	0.000597	0.00264	CcSEcCtD
Alfentanil—Headache—Mometasone—systemic scleroderma	0.000597	0.00264	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000595	0.00264	CcSEcCtD
Alfentanil—Fatigue—Leflunomide—systemic scleroderma	0.000594	0.00263	CcSEcCtD
Alfentanil—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000592	0.00262	CcSEcCtD
Alfentanil—Pruritus—Captopril—systemic scleroderma	0.000592	0.00262	CcSEcCtD
Alfentanil—Pain—Leflunomide—systemic scleroderma	0.00059	0.00261	CcSEcCtD
Alfentanil—Somnolence—Mycophenolic acid—systemic scleroderma	0.000585	0.00259	CcSEcCtD
Alfentanil—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000584	0.00259	CcSEcCtD
Alfentanil—Tachycardia—Lisinopril—systemic scleroderma	0.000578	0.00256	CcSEcCtD
Alfentanil—Body temperature increased—Azathioprine—systemic scleroderma	0.000577	0.00256	CcSEcCtD
Alfentanil—Skin disorder—Lisinopril—systemic scleroderma	0.000575	0.00255	CcSEcCtD
Alfentanil—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000573	0.00254	CcSEcCtD
Alfentanil—Feeling abnormal—Leflunomide—systemic scleroderma	0.000568	0.00252	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000568	0.00251	CcSEcCtD
Alfentanil—Fatigue—Mycophenolic acid—systemic scleroderma	0.000567	0.00251	CcSEcCtD
Alfentanil—Nausea—Mometasone—systemic scleroderma	0.000566	0.0025	CcSEcCtD
Alfentanil—Pain—Mycophenolic acid—systemic scleroderma	0.000562	0.00249	CcSEcCtD
Alfentanil—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000559	0.00247	CcSEcCtD
Alfentanil—Cough—Mycophenolate mofetil—systemic scleroderma	0.000555	0.00246	CcSEcCtD
Alfentanil—Hypotension—Lisinopril—systemic scleroderma	0.000554	0.00245	CcSEcCtD
Alfentanil—Dizziness—Captopril—systemic scleroderma	0.000553	0.00245	CcSEcCtD
Alfentanil—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000551	0.00244	CcSEcCtD
Alfentanil—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000549	0.00243	CcSEcCtD
Alfentanil—Urticaria—Leflunomide—systemic scleroderma	0.000548	0.00242	CcSEcCtD
Alfentanil—Body temperature increased—Leflunomide—systemic scleroderma	0.000545	0.00241	CcSEcCtD
Alfentanil—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000542	0.0024	CcSEcCtD
Alfentanil—Hypersensitivity—Azathioprine—systemic scleroderma	0.000538	0.00238	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000538	0.00238	CcSEcCtD
Alfentanil—Vomiting—Captopril—systemic scleroderma	0.000532	0.00235	CcSEcCtD
Alfentanil—Rash—Captopril—systemic scleroderma	0.000527	0.00234	CcSEcCtD
Alfentanil—Dermatitis—Captopril—systemic scleroderma	0.000527	0.00233	CcSEcCtD
Alfentanil—Somnolence—Lisinopril—systemic scleroderma	0.000527	0.00233	CcSEcCtD
Alfentanil—Headache—Captopril—systemic scleroderma	0.000524	0.00232	CcSEcCtD
Alfentanil—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000523	0.00232	CcSEcCtD
Alfentanil—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00052	0.0023	CcSEcCtD
Alfentanil—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000519	0.0023	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000511	0.00226	CcSEcCtD
Alfentanil—Fatigue—Lisinopril—systemic scleroderma	0.000511	0.00226	CcSEcCtD
Alfentanil—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000509	0.00225	CcSEcCtD
Alfentanil—Hypersensitivity—Leflunomide—systemic scleroderma	0.000508	0.00225	CcSEcCtD
Alfentanil—Pain—Lisinopril—systemic scleroderma	0.000507	0.00224	CcSEcCtD
Alfentanil—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000507	0.00224	CcSEcCtD
Alfentanil—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000504	0.00223	CcSEcCtD
Alfentanil—Bradycardia—Prednisone—systemic scleroderma	0.000504	0.00223	CcSEcCtD
Alfentanil—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000502	0.00222	CcSEcCtD
Alfentanil—Nausea—Captopril—systemic scleroderma	0.000497	0.0022	CcSEcCtD
Alfentanil—Asthenia—Leflunomide—systemic scleroderma	0.000495	0.00219	CcSEcCtD
Alfentanil—Feeling abnormal—Lisinopril—systemic scleroderma	0.000488	0.00216	CcSEcCtD
Alfentanil—Pruritus—Leflunomide—systemic scleroderma	0.000488	0.00216	CcSEcCtD
Alfentanil—Connective tissue disorder—Prednisone—systemic scleroderma	0.000487	0.00215	CcSEcCtD
Alfentanil—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000485	0.00215	CcSEcCtD
Alfentanil—Dizziness—Azathioprine—systemic scleroderma	0.000483	0.00214	CcSEcCtD
Alfentanil—Asthenia—Mycophenolic acid—systemic scleroderma	0.000472	0.00209	CcSEcCtD
Alfentanil—Urticaria—Lisinopril—systemic scleroderma	0.000471	0.00208	CcSEcCtD
Alfentanil—Body temperature increased—Lisinopril—systemic scleroderma	0.000468	0.00207	CcSEcCtD
Alfentanil—Pruritus—Mycophenolic acid—systemic scleroderma	0.000465	0.00206	CcSEcCtD
Alfentanil—Vomiting—Azathioprine—systemic scleroderma	0.000464	0.00206	CcSEcCtD
Alfentanil—Eye disorder—Prednisone—systemic scleroderma	0.000463	0.00205	CcSEcCtD
Alfentanil—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000461	0.00204	CcSEcCtD
Alfentanil—Drowsiness—Methotrexate—systemic scleroderma	0.000461	0.00204	CcSEcCtD
Alfentanil—Rash—Azathioprine—systemic scleroderma	0.00046	0.00204	CcSEcCtD
Alfentanil—Dermatitis—Azathioprine—systemic scleroderma	0.00046	0.00204	CcSEcCtD
Alfentanil—Headache—Azathioprine—systemic scleroderma	0.000457	0.00202	CcSEcCtD
Alfentanil—Dizziness—Leflunomide—systemic scleroderma	0.000456	0.00202	CcSEcCtD
Alfentanil—Angiopathy—Prednisone—systemic scleroderma	0.000449	0.00199	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000448	0.00198	CcSEcCtD
Alfentanil—Immune system disorder—Prednisone—systemic scleroderma	0.000447	0.00198	CcSEcCtD
Alfentanil—Pain—Mycophenolate mofetil—systemic scleroderma	0.000444	0.00197	CcSEcCtD
Alfentanil—Arrhythmia—Prednisone—systemic scleroderma	0.000442	0.00196	CcSEcCtD
Alfentanil—Vomiting—Leflunomide—systemic scleroderma	0.000438	0.00194	CcSEcCtD
Alfentanil—Hypersensitivity—Lisinopril—systemic scleroderma	0.000436	0.00193	CcSEcCtD
Alfentanil—Dizziness—Mycophenolic acid—systemic scleroderma	0.000435	0.00193	CcSEcCtD
Alfentanil—Epistaxis—Methotrexate—systemic scleroderma	0.000435	0.00193	CcSEcCtD
Alfentanil—Rash—Leflunomide—systemic scleroderma	0.000435	0.00192	CcSEcCtD
Alfentanil—Dermatitis—Leflunomide—systemic scleroderma	0.000434	0.00192	CcSEcCtD
Alfentanil—Mental disorder—Prednisone—systemic scleroderma	0.000434	0.00192	CcSEcCtD
Alfentanil—Nausea—Azathioprine—systemic scleroderma	0.000434	0.00192	CcSEcCtD
Alfentanil—Headache—Leflunomide—systemic scleroderma	0.000432	0.00191	CcSEcCtD
Alfentanil—Erythema—Prednisone—systemic scleroderma	0.000431	0.00191	CcSEcCtD
Alfentanil—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000428	0.00189	CcSEcCtD
Alfentanil—Asthenia—Lisinopril—systemic scleroderma	0.000425	0.00188	CcSEcCtD
Alfentanil—Pruritus—Lisinopril—systemic scleroderma	0.000419	0.00186	CcSEcCtD
Alfentanil—Vomiting—Mycophenolic acid—systemic scleroderma	0.000418	0.00185	CcSEcCtD
Alfentanil—Rash—Mycophenolic acid—systemic scleroderma	0.000415	0.00184	CcSEcCtD
Alfentanil—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000414	0.00183	CcSEcCtD
Alfentanil—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000412	0.00183	CcSEcCtD
Alfentanil—Headache—Mycophenolic acid—systemic scleroderma	0.000412	0.00182	CcSEcCtD
Alfentanil—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00041	0.00182	CcSEcCtD
Alfentanil—Nausea—Leflunomide—systemic scleroderma	0.00041	0.00181	CcSEcCtD
Alfentanil—Vision blurred—Prednisone—systemic scleroderma	0.000406	0.0018	CcSEcCtD
Alfentanil—Visual impairment—Methotrexate—systemic scleroderma	0.000399	0.00177	CcSEcCtD
Alfentanil—Agitation—Prednisone—systemic scleroderma	0.000396	0.00175	CcSEcCtD
Alfentanil—Dizziness—Lisinopril—systemic scleroderma	0.000392	0.00173	CcSEcCtD
Alfentanil—Nausea—Mycophenolic acid—systemic scleroderma	0.000391	0.00173	CcSEcCtD
Alfentanil—Eye disorder—Methotrexate—systemic scleroderma	0.000387	0.00171	CcSEcCtD
Alfentanil—Cardiac disorder—Methotrexate—systemic scleroderma	0.000384	0.0017	CcSEcCtD
Alfentanil—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000382	0.00169	CcSEcCtD
Alfentanil—Loss of consciousness—Prednisone—systemic scleroderma	0.000379	0.00168	CcSEcCtD
Alfentanil—Vomiting—Lisinopril—systemic scleroderma	0.000377	0.00167	CcSEcCtD
Alfentanil—Angiopathy—Methotrexate—systemic scleroderma	0.000376	0.00166	CcSEcCtD
Alfentanil—Immune system disorder—Methotrexate—systemic scleroderma	0.000374	0.00166	CcSEcCtD
Alfentanil—Rash—Lisinopril—systemic scleroderma	0.000374	0.00165	CcSEcCtD
Alfentanil—Convulsion—Prednisone—systemic scleroderma	0.000374	0.00165	CcSEcCtD
Alfentanil—Dermatitis—Lisinopril—systemic scleroderma	0.000373	0.00165	CcSEcCtD
Alfentanil—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000373	0.00165	CcSEcCtD
Alfentanil—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000372	0.00165	CcSEcCtD
Alfentanil—Hypertension—Prednisone—systemic scleroderma	0.000372	0.00165	CcSEcCtD
Alfentanil—Chills—Methotrexate—systemic scleroderma	0.000371	0.00164	CcSEcCtD
Alfentanil—Headache—Lisinopril—systemic scleroderma	0.000371	0.00164	CcSEcCtD
Alfentanil—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000367	0.00163	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000364	0.00161	CcSEcCtD
Alfentanil—Mental disorder—Methotrexate—systemic scleroderma	0.000363	0.00161	CcSEcCtD
Alfentanil—Erythema—Methotrexate—systemic scleroderma	0.00036	0.0016	CcSEcCtD
Alfentanil—Nausea—Lisinopril—systemic scleroderma	0.000352	0.00156	CcSEcCtD
Alfentanil—Anaphylactic shock—Prednisone—systemic scleroderma	0.000352	0.00156	CcSEcCtD
Alfentanil—Nervous system disorder—Prednisone—systemic scleroderma	0.000345	0.00153	CcSEcCtD
Alfentanil—Tachycardia—Prednisone—systemic scleroderma	0.000343	0.00152	CcSEcCtD
Alfentanil—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000343	0.00152	CcSEcCtD
Alfentanil—Skin disorder—Prednisone—systemic scleroderma	0.000342	0.00151	CcSEcCtD
Alfentanil—Hyperhidrosis—Prednisone—systemic scleroderma	0.00034	0.00151	CcSEcCtD
Alfentanil—Vision blurred—Methotrexate—systemic scleroderma	0.00034	0.0015	CcSEcCtD
Alfentanil—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00033	0.00146	CcSEcCtD
Alfentanil—Rash—Mycophenolate mofetil—systemic scleroderma	0.000327	0.00145	CcSEcCtD
Alfentanil—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000327	0.00145	CcSEcCtD
Alfentanil—Headache—Mycophenolate mofetil—systemic scleroderma	0.000325	0.00144	CcSEcCtD
Alfentanil—Cough—Methotrexate—systemic scleroderma	0.000314	0.00139	CcSEcCtD
Alfentanil—Convulsion—Methotrexate—systemic scleroderma	0.000312	0.00138	CcSEcCtD
Alfentanil—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000308	0.00136	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000305	0.00135	CcSEcCtD
Alfentanil—Fatigue—Prednisone—systemic scleroderma	0.000303	0.00134	CcSEcCtD
Alfentanil—Confusional state—Methotrexate—systemic scleroderma	0.000296	0.00131	CcSEcCtD
Alfentanil—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000294	0.0013	CcSEcCtD
Alfentanil—Feeling abnormal—Prednisone—systemic scleroderma	0.00029	0.00128	CcSEcCtD
Alfentanil—Nervous system disorder—Methotrexate—systemic scleroderma	0.000288	0.00128	CcSEcCtD
Alfentanil—Skin disorder—Methotrexate—systemic scleroderma	0.000286	0.00126	CcSEcCtD
Alfentanil—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000284	0.00126	CcSEcCtD
Alfentanil—Urticaria—Prednisone—systemic scleroderma	0.00028	0.00124	CcSEcCtD
Alfentanil—Body temperature increased—Prednisone—systemic scleroderma	0.000278	0.00123	CcSEcCtD
Alfentanil—Hypotension—Methotrexate—systemic scleroderma	0.000275	0.00122	CcSEcCtD
Alfentanil—Somnolence—Methotrexate—systemic scleroderma	0.000261	0.00116	CcSEcCtD
Alfentanil—Hypersensitivity—Prednisone—systemic scleroderma	0.000259	0.00115	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000254	0.00112	CcSEcCtD
Alfentanil—Fatigue—Methotrexate—systemic scleroderma	0.000254	0.00112	CcSEcCtD
Alfentanil—Asthenia—Prednisone—systemic scleroderma	0.000252	0.00112	CcSEcCtD
Alfentanil—Pain—Methotrexate—systemic scleroderma	0.000251	0.00111	CcSEcCtD
Alfentanil—Pruritus—Prednisone—systemic scleroderma	0.000249	0.0011	CcSEcCtD
Alfentanil—Feeling abnormal—Methotrexate—systemic scleroderma	0.000242	0.00107	CcSEcCtD
Alfentanil—Urticaria—Methotrexate—systemic scleroderma	0.000234	0.00103	CcSEcCtD
Alfentanil—Dizziness—Prednisone—systemic scleroderma	0.000233	0.00103	CcSEcCtD
Alfentanil—Body temperature increased—Methotrexate—systemic scleroderma	0.000232	0.00103	CcSEcCtD
Alfentanil—Vomiting—Prednisone—systemic scleroderma	0.000224	0.00099	CcSEcCtD
Alfentanil—Rash—Prednisone—systemic scleroderma	0.000222	0.000982	CcSEcCtD
Alfentanil—Dermatitis—Prednisone—systemic scleroderma	0.000222	0.000981	CcSEcCtD
Alfentanil—Headache—Prednisone—systemic scleroderma	0.00022	0.000976	CcSEcCtD
Alfentanil—Hypersensitivity—Methotrexate—systemic scleroderma	0.000217	0.000959	CcSEcCtD
Alfentanil—Asthenia—Methotrexate—systemic scleroderma	0.000211	0.000934	CcSEcCtD
Alfentanil—Nausea—Prednisone—systemic scleroderma	0.000209	0.000925	CcSEcCtD
Alfentanil—Pruritus—Methotrexate—systemic scleroderma	0.000208	0.000921	CcSEcCtD
Alfentanil—Dizziness—Methotrexate—systemic scleroderma	0.000194	0.000861	CcSEcCtD
Alfentanil—Vomiting—Methotrexate—systemic scleroderma	0.000187	0.000828	CcSEcCtD
Alfentanil—Rash—Methotrexate—systemic scleroderma	0.000185	0.000821	CcSEcCtD
Alfentanil—Dermatitis—Methotrexate—systemic scleroderma	0.000185	0.00082	CcSEcCtD
Alfentanil—Headache—Methotrexate—systemic scleroderma	0.000184	0.000816	CcSEcCtD
Alfentanil—Nausea—Methotrexate—systemic scleroderma	0.000175	0.000773	CcSEcCtD
